SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-21-004741
Filing Date
2021-11-04
Accepted
2021-11-04 16:58:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 AURA BIOSCIENCES, INC. p21-2409sc13d.htm SC 13D 63642
2 EXHIBIT A p21-2409exhibita.htm EX-99 3944
  Complete submission text file 0000902664-21-004741.txt   69233
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

IRS No.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Subject) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92997 | Film No.: 211380922
SIC: 2836 Biological Products, (No Diagnostic Substances)